Glooko

Glooko

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $88.5M

Overview

Glooko is a US-based digital health company, founded in 2010, that provides a unified data management platform for diabetes care. The platform aggregates and visualizes data from over 200 compatible diabetes and health monitoring devices, enabling remote patient monitoring and data-driven clinical decisions. It targets two main customer segments: healthcare providers seeking to streamline clinical workflows and patients aiming to better understand and manage their condition. The company is committed to high standards of data security and regulatory compliance, including CE Marking as a Class IIa medical device and adherence to GDPR and ISO 27001.

Diabetes

Technology Platform

A cloud-based data aggregation and analytics platform that syncs with over 200 compatible diabetes and health monitoring devices (glucose meters, CGMs, insulin pumps, smart pens, fitness trackers). It provides unified data visualization, remote patient monitoring tools, and integrates into clinical workflows for healthcare providers.

Funding History

4
Total raised:$88.5M
Series D$30M
Series C$35M
Series B$16.5M
Series A$7M

Opportunities

The global rise in diabetes prevalence and the shift towards telehealth and value-based care create a large, growing market for data management platforms.
Glooko can leverage its aggregated dataset to develop advanced predictive analytics and personalized insights, and potentially expand its platform to manage adjacent chronic conditions like obesity or hypertension.

Risk Factors

Intense competition from device manufacturers' own apps, large tech companies, and other digital health startups.
Regulatory hurdles in maintaining global medical device compliance (e.g., EU MDR) are ongoing.
Data security breaches pose an existential threat, and growth depends on continued partnerships with device makers and adoption by healthcare providers facing budget and integration challenges.

Competitive Landscape

Glooko competes in a crowded digital diabetes management space. Direct competitors include other data aggregation platforms like Tidepool and mySugr. It also faces competition from device-centric ecosystems from major CGM and pump manufacturers (Dexcom Clarity, Abbott LibreView, Tandem t:connect), and potential competition from broad health data platforms from large technology firms. Its key differentiator is its extensive, device-agnostic compatibility.